The Food and Drug Administration on Friday approved a new antibiotic from Cubist Pharmaceuticals to treat common skin infections often acquired in hospital.
By unleashing the immune system to attack skin cancer, researchers have made important strides against melanoma, according to the results of three clinical trials released Monday.
German drugmaker Boehringer Ingelheim said Wednesday it has agreed to pay US$650 million to settle thousands of U.S. claims questioning the marketing and safety of its popular blood thinner Pradaxa.
Lita (利達) Pharmacy Co. in Taichung City is believed to have defrauded Taiwan's National Health Insurance system of more than NT$70 million (US$2.35 million) from 2011 to 2013, Taichung District Prosecutors Office said Friday.
A single daily pill may help prevent HIV. And in the United States, gay men who have lost countless loved ones to AIDS can't stop fighting about it.
An experimental antiviral drug taken orally could help contribute to the eradication of measles, an infection responsible for thousands of deaths per year, scientists said in a report Wednesday.
U.S. regulators on Thursday approved a handheld injector device that average people could use in an emergency to revive a person suspected of overdosing on prescription painkillers.
Nearly every male and most women over 55 could fall under new U.S. guidelines for who should take cholesterol lowering drugs, researchers said Saturday, stirring fresh controversy in the medical world.
A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.
Pfizer Inc. said Wednesday that its blockbuster vaccine against pneumonia, blood and other infections met its goal of preventing illness in vulnerable elderly patients in a huge study required by U.S. regulators.